Physician profile
Daniel Debo
NPI 1447254040
$7,240.34
in general payments reported to CMS, 2019-2025
34 companies · $1,969 in 2025
The $1,969 reported for 2025 was more than what 79% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $13.12 · 2021: $573 · 2022: $1,302 · 2023: $1,489 · 2024: $1,608 · 2025: $1,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,066.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,338.09 | 2021-2025 | Rinvoq, Linzess, Viberzi |
| Takeda Pharmaceuticals U.S.A., INC. | $795.50 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Janssen Biotech, INC. | $738.66 | 2021-2025 | Tremfya, Stelara, Simponi |
| Regeneron Healthcare Solutions, INC. | $662.80 | 2022-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $449.18 | 2019-2025 | Xifaxan, Trulance |
| Qol Medical, LLC | $386.39 | 2021-2025 | Sucraid, Sucraid |
| Janssen Scientific Affairs, LLC | $312.29 | 2022-2025 | Tremfya |
| Phathom Pharmaceuticals, INC. | $202.00 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $153.26 | 2023-2025 | Omvoh |
| Gilead Sciences, INC. | $147.43 | 2023-2025 | |
| Amgen INC. | $124.30 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $115.22 | 2022 | |
| Idorsia Pharmaceuticals US INC | $100.46 | 2023 | Quviviq |
| Ironwood Pharmaceuticals, INC | $98.71 | 2021-2025 | |
| Medtronic, INC. | $93.82 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $56.78 | 2022-2023 | |
| Genzyme Corporation | $51.79 | 2022-2023 | |
| Madrigal Pharmaceuticals | $49.62 | 2024 | Resmetirom |
| Celgene Corporation | $43.97 | 2022-2023 | Zeposia |
| Boston Scientific Corporation | $40.51 | 2023-2025 | Resolution Clip, Axonics |
| Intercept Pharmaceuticals, INC. | $35.03 | 2023-2024 | Ocaliva |
| Braintree Laboratories, INC. | $31.96 | 2019-2021 | |
| Allergan, INC. | $26.37 | 2019-2020 | |
| Ethicon US, LLC | $25.33 | 2022 | |
| Celltrion USA INC. | $22.17 | 2025 | Vegzelma |
| Medline Industries Lp | $18.70 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $17.53 | 2025 | Iqirvo |
| Pfizer INC. | $17.11 | 2019 | |
| Olympus America INC. | $16.24 | 2024 | Evis Exera III Colonovideoscope |
| Axonics, INC. | $15.68 | 2023 | Axonics |
| Aimmune Therapeutics, INC. | $14.08 | 2025 | Zenpep |
| Evoke Pharma, INC. | $14.05 | 2025 | |
| Merck Sharp & Dohme LLC | $13.18 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Debo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.